BIOC logo

GlaxoSmithKline S.A.E Stock Price

CASE:BIOC Community·ج.م39.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

BIOC Share Price Performance

ج.م473.00
422.00 (827.45%)
ج.م473.00
422.00 (827.45%)
Price ج.م473.00

BIOC Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Proven track record with mediocre balance sheet.

3 Risks
1 Reward

GlaxoSmithKline S.A.E Key Details

ج.م3.6b

Revenue

ج.م2.9b

Cost of Revenue

ج.م724.1m

Gross Profit

ج.م529.9m

Other Expenses

ج.م194.2m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
2.33
20.01%
5.37%
80.0%
View Full Analysis

About BIOC

Founded
1981
Employees
n/a
CEO
Heba El Morshedy
WebsiteView website
www.gsk.com/en-gb/contact-us/worldwide/egypt

GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

Recent BIOC News & Updates

Recent updates

No updates

GlaxoSmithKline S.A.E Competitors